Palmitic acid-1-14C incorporation and turnover in lung phospholipids of rats treated with chlorphentermine, RMI 10.393 and Ro 4-4318.
The effects of 3 lipidosis-inducing drugs on the incorporation and turnover of palmitic acid-1-14C in lung phospholipids was studied. In rats treated with 1 dose of chlorphentermine or RMI 10.393, the incorporation of palmitate-1-14C into most lung phospholipid fractions was moderately decreased, but markedly lowered after 1 dose of Ro 4-4318. Eight doses of chlorphentermine and RMI 10.393 strongly inhibited the incorporation of palmitate-1-14C into lung phospholipids, whereas with 8 doses of Ro 4-4318 the incorporation was highly increased. Thirty hours after the last of 3 injections of the labeled palmitic acid the turnover of most lung phospholipids was considerably lower in chlorphentermine- and RMI 10.393-treated rats than in controls. Ro 4-4318, however, induced a highly increased turnover of most phospholipids. After 54 h, this effect had practically disappeared. Our studies showed that phospholipid storage after treatment with chlorphentermine and RMI 10.393 is mainly due to decreased degradation of phospholipids, whereas increased synthesis accounts for the effect of Ro 4-4318.
D000639:Amitriptyline / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D002745:Chlorphentermine / Q000494:pharmacology*; D005260:Female; D005449:Fluorenes / Q000494:pharmacology*; D008064:Lipidoses / Q000139:chemically induced; D008168:Lung / Q000378:metabolism*; D010169:Palmitic Acids / Q000378:metabolism*; D010645:Phentermine / Q000031:analogs & derivatives*; D010743:Phospholipids / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats
D005449:Fluorenes; D010169:Palmitic Acids; D010743:Phospholipids; D010880:Piperidines; D000639:Amitriptyline; C006304:1-chloroamitriptyline; D010645:Phentermine; D002745:Chlorphentermine